With regard to the use of mefloquine by members of the Canadian Armed Forces as an anti-malaria drug as directed by the Minister of National Defence: (a) how many Canadian Armed Forces members have been given mefloquine annually in each of the years since mefloquine was first used by the Canadian Armed Forces in 1993; (b) what other anti-malaria drugs has the Canadian Armed Forces administered to forces members; (c) what year did the Canadian Armed Forces change the use of mefloquine from mandatory to optional for Canadian Armed Forces members; (d) how many members of the Canadian Armed Forces have been returned to Canada from deployment for not taking or refusing mefloquine; and (e) how many Canadian Armed Forces members were refused deployment to a mission for refusing to take mefloquine?
In the House of Commons on April 6th, 2017. See this statement in context.